Sfoglia per Autore
Alcoholic liver disease: pathophisiological aspects and risk factors. A review.
2006 Gramenzi A; Caputo F; Biselli M; Kuria F; Loggi E; Andreone P; Bernardi M.
Adefovir and lamivudine combination therapy is superior to ADV monotherapy for lamivudine-resistant patients with HBeAG-negative chronic hepatitis B
2007 P. Lampertico; A. Marzano; M. Levrero; T. Santantonio; V. Di Marco; M. Brunetto; P. Andreone; E. Sagnelli; S. Fagiuoli; G. Mazzella; G. Raimondo; G.B. Gaeta; A. Ascione and On behalf of the AISF Adefovir Study Group
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses
2007 De Mitri MS; Morsica G; Cassini R; Bagaglio S; Andreone P; Bianchi G; Loggi E; Bernardi M.
PRELIMINARY RESULTS OF METRONOMIC CAPECITABINE TREATMENT IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC).
2007 Brandi G; Fanello S; Piscaglia F; FalangaA; Balducci D; Vignoli A; Flori S; Costantini S; Andreone P; Morelli C; Bolondi L; Biasco G.
Regenerative Medicine and liver injury: what role for bone marrow derived stem cells?
2007 S. Lorenzini; P. Andreone
Prophylaxis and treatment of hepatitis B in immunocompromised patients.
2007 Marzano A.; Angelucci E.; Andreone P.; Brunetto M.; Bruno R.; Burra P.; Caraceni P.; Daniele B.; Di Marco V.; Fabrizi F.; Fagiuoli S.; Grossi P.; Lampertico P.; Meliconi R.; Mangia A.; Puoti M.; Raimondo G.; Smedile A.
Evolution of hepatitis C vitus non structural 5A gene (NS5A) in the progression of liver disease to hepatocellular carcinoma.
2007 De Mitri MS; Cassini R; Bagaglio S; Morsica G; Andreone P; Marino N; Bernardi M.
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C.
2007 Gramenzi A; Andreone P; Cursaro C; Verucchi G; Boccia S; Giacomoni PL; Galli S; Furlini G; Biselli M; Lorenzini S; Attard L; Bonvicini F; Bernardi M.
Clinical and serological profile of primary biliary cirrhosis in men.
2007 Muratori P; Granito A; Pappas G; Muratori L; Quarneti C; De Molo C; Cipriano V; Vukotic R; Andreone P; Lenzi M; Bianchi FB.
Stem cell therapy for human liver cirrhosis: a cautious analysis of the results
2007 S. Lorenzini; P. Andreone
Comparing and combining gamma-hydroxybutiric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomized comparative study.
2007 Caputo F; Addolorato G; Stoppo M; Francini S; Vignoli T; Lorenzini F; Del Re A; Comaschi C; Andreone P; Trevisani F; Bernardi M.
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study
2007 S. Bruno; T. Stroffolini; M. Colombo;S. Bollani; L. Benvegnu; G. Mazzella; A. Ascione; T. Santantonio; F. Piccinino; P. Andreone; A. Mangia; G.B. Gaeta; M. Persico; S. Fagiuoli; P.L. Almasio
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
2007 Franco Trevisani; Giulia Magini; Valentina Santi; Antonio Maria Morselli-Labate; Maria Chiara Cantarini; Maria Anna Di Nolfo; Paolo Del Poggio; Luisa Benvegnù; Gianludovico Rapaccini; Fabio Farinati; Marco Zoli; Franco Borzio; Edoardo Giovanni Giannini; Eugenio Caturelli; Mauro Bernardi; for the Italian Liver Cancer (ITA.LI.CA) Group; Pietro Andreone; Maurizio Biselli; Paolo Caraceni; Maria Chiara Cantarini; Carmela Cursaro; Marco Domenicali; Annagiulia Gramenzi; Silvia Li Bassi; Donatella Magalotti; Federica Mirici Cappa; Andrea Zambruni; Gian Luca Grazi; Bruno Nardo; Matteo Ravaioli; Cristina Rossi; Rita Golfieri
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
2007 Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia F; Biselli M; Sama C; Mazzella G; Pinna AD; Bernardi M; Andreone P.
G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence.
2008 F. Lodato; M.R. Tamè; M. Di Girolamo; F. Azzaroli; A. Gramenzi; S. Berardi; P. Andreone; A.D. Pinna; E. Roda; D. Festi; G. Mazzella
Stem cells for end stage liver disease: How far have we got?
2008 Lorenzini S; Gitto S; Grandini E; Andreone P; Bernardi M.
Anti-synthetase syndrome with lung involvement associated with primary biliary cirrhosis: A case report
2008 D'Avanzo M.; Fasano L.; Pacilli A.M.G.; Carbonara P.; Di Scioscio V.; Salfi N.; Vitale G.; Andreone P.; Fabbri M.
G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence
2008 Lodato F ; Tame MR ; Di Girolamo M ; Azzaroli F; Gramenzi A ; Berardi S ; Andreone P ; Pinna AD ; Roda E ; Mazzella G .
Hepatitis B virus and immune response.
2008 Fiorino S; Vukotic R; Loggi E; Vitale G; Cursaro C; Gramenzi A; Micco L; Fortini C; Cuppini A; Bernardi M; Andreone P.
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation
2008 Lodato F; Berardi S; Gramenzi A; Mazzella G; Lenzi M; Morelli MC; Tame MR; Piscaglia F; Andreone P; Bologna Liver Transplantation Group (BLTG) [..; Ballardini G; Bernardi M; Bianchi FB; Biselli M; Bolondi L; Cescon M; Colecchia A; D'Errico A; Del Gaudio M; Ercolani G; Grazi GL; Grigioni W; Lorenzini S; Pinna AD; Ravaioli M; Roda E; Sama C; Vivarelli M.; ..]
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Alcoholic liver disease: pathophisiological aspects and risk factors. A review. | Gramenzi A; Caputo F; Biselli M; Kuria F; Loggi E; Andreone P; Bernardi M. | 2006-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Adefovir and lamivudine combination therapy is superior to ADV monotherapy for lamivudine-resistant patients with HBeAG-negative chronic hepatitis B | P. Lampertico; A. Marzano; M. Levrero; T. Santantonio; V. Di Marco; M. Brunetto; P. Andreone; E. ...Sagnelli; S. Fagiuoli; G. Mazzella; G. Raimondo; G.B. Gaeta; A. Ascione and On behalf of the AISF Adefovir Study Group | 2007-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
| Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses | De Mitri MS; Morsica G; Cassini R; Bagaglio S; Andreone P; Bianchi G; Loggi E; Bernardi M. | 2007-01-01 | ARCHIVES OF VIROLOGY | - | 1.01 Articolo in rivista | - |
| PRELIMINARY RESULTS OF METRONOMIC CAPECITABINE TREATMENT IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC). | Brandi G; Fanello S; Piscaglia F; FalangaA; Balducci D; Vignoli A; Flori S; Costantini S; Andreon...e P; Morelli C; Bolondi L; Biasco G. | 2007-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Regenerative Medicine and liver injury: what role for bone marrow derived stem cells? | S. Lorenzini; P. Andreone | 2007-01-01 | CURRENT STEM CELL RESEARCH & THERAPY | - | 1.01 Articolo in rivista | - |
| Prophylaxis and treatment of hepatitis B in immunocompromised patients. | Marzano A.; Angelucci E.; Andreone P.; Brunetto M.; Bruno R.; Burra P.; Caraceni P.; Daniele B.; ...Di Marco V.; Fabrizi F.; Fagiuoli S.; Grossi P.; Lampertico P.; Meliconi R.; Mangia A.; Puoti M.; Raimondo G.; Smedile A. | 2007-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
| Evolution of hepatitis C vitus non structural 5A gene (NS5A) in the progression of liver disease to hepatocellular carcinoma. | De Mitri MS; Cassini R; Bagaglio S; Morsica G; Andreone P; Marino N; Bernardi M. | 2007-01-01 | LIVER INTERNATIONAL | - | 1.01 Articolo in rivista | - |
| A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C. | Gramenzi A; Andreone P; Cursaro C; Verucchi G; Boccia S; Giacomoni PL; Galli S; Furlini G; Bisell...i M; Lorenzini S; Attard L; Bonvicini F; Bernardi M. | 2007-01-01 | JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Clinical and serological profile of primary biliary cirrhosis in men. | Muratori P; Granito A; Pappas G; Muratori L; Quarneti C; De Molo C; Cipriano V; Vukotic R; Andreo...ne P; Lenzi M; Bianchi FB. | 2007-01-01 | QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | - | 1.04 Replica / breve intervento (e simili) | - |
| Stem cell therapy for human liver cirrhosis: a cautious analysis of the results | S. Lorenzini; P. Andreone | 2007-01-01 | STEM CELLS | - | 1.01 Articolo in rivista | - |
| Comparing and combining gamma-hydroxybutiric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomized comparative study. | Caputo F; Addolorato G; Stoppo M; Francini S; Vignoli T; Lorenzini F; Del Re A; Comaschi C; Andre...one P; Trevisani F; Bernardi M. | 2007-01-01 | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study | S. Bruno; T. Stroffolini; M. Colombo;S. Bollani; L. Benvegnu; G. Mazzella; A. Ascione; T. Santant...onio; F. Piccinino; P. Andreone; A. Mangia; G.B. Gaeta; M. Persico; S. Fagiuoli; P.L. Almasio | 2007-01-01 | HEPATOLOGY | - | 1.01 Articolo in rivista | - |
| Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. | Franco Trevisani; Giulia Magini; Valentina Santi; Antonio Maria Morselli-Labate; Maria Chiara Can...tarini; Maria Anna Di Nolfo; Paolo Del Poggio; Luisa Benvegnù; Gianludovico Rapaccini; Fabio Farinati; Marco Zoli; Franco Borzio; Edoardo Giovanni Giannini; Eugenio Caturelli; Mauro Bernardi; for the Italian Liver Cancer (ITA.LI.CA) Group; Pietro Andreone; Maurizio Biselli; Paolo Caraceni; Maria Chiara Cantarini; Carmela Cursaro; Marco Domenicali; Annagiulia Gramenzi; Silvia Li Bassi; Donatella Magalotti; Federica Mirici Cappa; Andrea Zambruni; Gian Luca Grazi; Bruno Nardo; Matteo Ravaioli; Cristina Rossi; Rita Golfieri | 2007-01-01 | THE AMERICAN JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? | Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia... F; Biselli M; Sama C; Mazzella G; Pinna AD; Bernardi M; Andreone P. | 2007-01-01 | GUT | - | 1.01 Articolo in rivista | - |
| G-CSF administration is not related to Peg-IFN alfa-2b treatment duration nor response in liver transplanted patients with HCV recurrence. | F. Lodato; M.R. Tamè; M. Di Girolamo; F. Azzaroli; A. Gramenzi; S. Berardi; P. Andreone; A.D. Pin...na; E. Roda; D. Festi; G. Mazzella | 2008-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
| Stem cells for end stage liver disease: How far have we got? | Lorenzini S; Gitto S; Grandini E; Andreone P; Bernardi M. | 2008-01-01 | WORLD JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Anti-synthetase syndrome with lung involvement associated with primary biliary cirrhosis: A case report | D'Avanzo M.; Fasano L.; Pacilli A.M.G.; Carbonara P.; Di Scioscio V.; Salfi N.; Vitale G.; Andreo...ne P.; Fabbri M. | 2008-01-01 | RESPIRATORY MEDICINE CME | - | 1.01 Articolo in rivista | - |
| G-CSF administration is not related to PEG-IFN alfa-213 treatment duration nor response in liver transplanted patients with HCV recurrence | Lodato F ; Tame MR ; Di Girolamo M ; Azzaroli F; Gramenzi A ; Berardi S ; Andreone P ; Pinna AD ;... Roda E ; Mazzella G . | 2008-01-01 | JOURNAL OF HEPATOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Hepatitis B virus and immune response. | Fiorino S; Vukotic R; Loggi E; Vitale G; Cursaro C; Gramenzi A; Micco L; Fortini C; Cuppini A; Be...rnardi M; Andreone P. | 2008-01-01 | - | Nova Science Publishers Inc | 3.01 Monografia / trattato scientifico in forma di libro | - |
| Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation | Lodato F; Berardi S; Gramenzi A; Mazzella G; Lenzi M; Morelli MC; Tame MR; Piscaglia F; Andreone ...P; Bologna Liver Transplantation Group (BLTG) [..; Ballardini G; Bernardi M; Bianchi FB; Biselli M; Bolondi L; Cescon M; Colecchia A; D'Errico A; Del Gaudio M; Ercolani G; Grazi GL; Grigioni W; Lorenzini S; Pinna AD; Ravaioli M; Roda E; Sama C; Vivarelli M.; ..] | 2008-01-01 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile